Physiological Replacement of T 3 Improves Left Ventricular Function in an Animal Model of Myocardial Infarction-Induced Congestive Heart Failure
- 1 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Heart Failure
- Vol. 2 (3) , 243-252
Abstract
Patients with congestive heart failure (CHF) often have low serum triiodothyronine (T(3)) concentrations. In a rodent model of myocardial infarction-induced CHF and low serum T(3), we hypothesized that replacing T(3) to euthyroid levels would improve left ventricular function without producing untoward signs of thyrotoxicosis. Adult male Sprague-Dawley rats were subjected to left anterior descending coronary artery ligation (myocardial infarction). One week post-myocardial infarction, left ventricular fractional shortening was significantly reduced to 22+/-1% in CHF animals versus 38+/-1% for sham-operated controls (P<0.001). Serum T(3) concentration was also significantly reduced (80+/-3 versus 103+/-6 ng/dL; P<0.001), in CHF animals versus Shams. At 9 weeks post-myocardial infarction, systolic function (+dP/dt max) was significantly attenuated in CHF animals (4773+/-259 versus 6310+/-267 mmHg/s; P<0.001) as well as diastolic function measured by half time to relaxation (15.9+/-1.2 versus 11.1+/-0.3 ms; P<0.001). alpha-myosin heavy chain expression was also significantly reduced by 77% (P<0.001), and beta-myosin heavy chain expression was increased by 21%. Continuous T(3) replacement was initiated 1 week post-myocardial infarction with osmotic mini-pumps (6 microg/kg/d), which returned serum T(3) concentrations to levels similar to Sham controls while resting conscious heart rate, arterial blood pressure and the incidence of arrhythmias were not different. At 9 weeks, systolic function was significantly improved by T(3) replacement (6279+/-347 mmHg/s; P<0.05) and a trend toward improved diastolic function (12.3+/-0.6 ms) was noted. T(3) replacement in CHF animals also significantly increased alpha- and reduced beta-MHC expression, (P<0.05). These data indicate that T(3) replacement to euthyroid levels improves systolic function and tends to improve diastolic function, potentially through changes in myocardial gene expression.Keywords
This publication has 49 references indexed in Scilit:
- CRNK gene transfer improves function and reverses the myosin heavy chain isoenzyme switch during post-myocardial infarction left ventricular remodelingJournal of Molecular and Cellular Cardiology, 2008
- Persistent alterations in heart rate variability, baroreflex sensitivity, and anxiety-like behaviors during development of heart failure in the ratAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Thyroid Hormone Treatment to Mend a Broken HeartThe Journal of Clinical Endocrinology & Metabolism, 2008
- Short term triiodo-l-thyronine treatment inhibits cardiac myocyte apoptosis in border area after myocardial infarction in ratsJournal of Molecular and Cellular Cardiology, 2008
- Regulation of Hepatocyte Thyroxine 5′-Deiodinase by T3 and Nuclear Receptor Coactivators as a Model of the Sick Euthyroid SyndromeJournal of Biological Chemistry, 2000
- Thyroid Hormone Regulation of Myocardial Na/K-ATPase Gene ExpressionJournal of Molecular and Cellular Cardiology, 2000
- Effects of Thyroid and Glucocorticoid Hormones on Kv1.5 Potassium Channel Gene Expression in the Rat Left VentricleBiochemical and Biophysical Research Communications, 1997
- Thyroid hormone regulates Na+-Ca2+ exchanger expression during postnatal maturation and in adult rabbit ventricular myocardiumCardiovascular Research, 1996
- Altered thyroid hormone metabolism in advanced heart failureJACC, 1990
- THYROID HORMONES IN ACUTE MYOCARDIAL INFARCTIONClinical Endocrinology, 1981